---
category: news
title: "Sosei Heptares and InveniAI Enter a Multi-target AI-powered and GPCR-focused Drug Discovery Collaboration"
excerpt: "Sosei Group Corporation (\"the Company\") (TSE: 4565), the world leader in GPCR-focused structure-based drug design and development,"
publishedDateTime: 2021-07-06T07:00:00Z
originalUrl: "https://www.prnewswire.com/news-releases/sosei-heptares-and-inveniai-enter-a-multi-target-ai-powered-and-gpcr-focused-drug-discovery-collaboration-301325815.html"
webUrl: "https://www.prnewswire.com/news-releases/sosei-heptares-and-inveniai-enter-a-multi-target-ai-powered-and-gpcr-focused-drug-discovery-collaboration-301325815.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI

secured: "zf94Wc+BmdeXLTy5hlxDoyAplvBbMsWAJkioPgdP2SbfQwvjD89QZ7OwlYfHrvcCZrft8Jy22NPNGAysnM74d4eXi0esXHyy+wv4r4f9iKtuERQKqBWryRgUiHKWeGzEFJT6/oxGICYkoBiO1gWzJXjNdA7lZbJ/a1wQbKBUpOynnn1h2dfE2/1vuAOYgKmwbTSQSmF/pKknjkUOqnkuBIMqLthasdUknxu8kqel9BAaO56IOfTRZsHjL14AJs1DYAYwvCWQG5a1XEMMcERCdc/xAOrVa2gxGliMm/Otwo+alatPmKL+ISgU41G6j5vhdOkMQdUWUjqQ5OdmwtQRzoAoiKUJm0eiLdnYR25hhew=;9XV5DcFvGpPEGCM3OoP5Aw=="
---

